Cargando…

The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration

OBJECTIVE: An ulcer categorized as Fontaine’s stage IV represents a chronic wound, risk factor of arteriosclerosis, and co-morbidities which disturb wound healing. Our objective was to analyze wound healing and to assess potential factors affecting the healing process. METHODS: 199 patients were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tautenhahn, Joerg, Lobmann, Ralf, Koenig, Brigitte, Halloul, Zuhir, Lippert, Hans, Buerger, Thomas
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515428/
https://www.ncbi.nlm.nih.gov/pubmed/18827918
_version_ 1782158427404894208
author Tautenhahn, Joerg
Lobmann, Ralf
Koenig, Brigitte
Halloul, Zuhir
Lippert, Hans
Buerger, Thomas
author_facet Tautenhahn, Joerg
Lobmann, Ralf
Koenig, Brigitte
Halloul, Zuhir
Lippert, Hans
Buerger, Thomas
author_sort Tautenhahn, Joerg
collection PubMed
description OBJECTIVE: An ulcer categorized as Fontaine’s stage IV represents a chronic wound, risk factor of arteriosclerosis, and co-morbidities which disturb wound healing. Our objective was to analyze wound healing and to assess potential factors affecting the healing process. METHODS: 199 patients were included in this 5-year study. The significance levels were determined by chi-squared and log-rank tests. The calculation of patency rate followed the Kaplan-Meier method. RESULTS: Mean age and co-morbidities did not differ from those in current epidemiological studies. Of the patients with ulcer latency of more than 13 weeks (up to one year), 40% required vascular surgery. Vascular surgery was not possible for 53 patients and they were treated conservatively. The amputation rate in the conservatively treated group was 37%, whereas in the revascularizated group it was only 16%. Ulcers in patients with revascularization healed in 92% of cases after 24 weeks. In contrast, we found a healing rate of only 40% in the conservatively treated group (p < 0.001). Revascularization appeared more often in diabetic patients (n = 110; p < 0.01) and the wound size and number of infections were elevated (p = 0.03). Among those treated conservatively, wound healing was decelerated (p = 0.01/0.02; χ(2) test). CONCLUSIONS: The success of revascularization, presence of diabetes mellitus, and wound treatment proved to be prognostic factors for wound healing in arterial ulcers.
format Text
id pubmed-2515428
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-25154282008-10-01 The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration Tautenhahn, Joerg Lobmann, Ralf Koenig, Brigitte Halloul, Zuhir Lippert, Hans Buerger, Thomas Vasc Health Risk Manag Original Research OBJECTIVE: An ulcer categorized as Fontaine’s stage IV represents a chronic wound, risk factor of arteriosclerosis, and co-morbidities which disturb wound healing. Our objective was to analyze wound healing and to assess potential factors affecting the healing process. METHODS: 199 patients were included in this 5-year study. The significance levels were determined by chi-squared and log-rank tests. The calculation of patency rate followed the Kaplan-Meier method. RESULTS: Mean age and co-morbidities did not differ from those in current epidemiological studies. Of the patients with ulcer latency of more than 13 weeks (up to one year), 40% required vascular surgery. Vascular surgery was not possible for 53 patients and they were treated conservatively. The amputation rate in the conservatively treated group was 37%, whereas in the revascularizated group it was only 16%. Ulcers in patients with revascularization healed in 92% of cases after 24 weeks. In contrast, we found a healing rate of only 40% in the conservatively treated group (p < 0.001). Revascularization appeared more often in diabetic patients (n = 110; p < 0.01) and the wound size and number of infections were elevated (p = 0.03). Among those treated conservatively, wound healing was decelerated (p = 0.01/0.02; χ(2) test). CONCLUSIONS: The success of revascularization, presence of diabetes mellitus, and wound treatment proved to be prognostic factors for wound healing in arterial ulcers. Dove Medical Press 2008-06 2008-06 /pmc/articles/PMC2515428/ /pubmed/18827918 Text en © 2008 Tautenhahn et al, publisher and licensee Dove Medical Press Ltd.
spellingShingle Original Research
Tautenhahn, Joerg
Lobmann, Ralf
Koenig, Brigitte
Halloul, Zuhir
Lippert, Hans
Buerger, Thomas
The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
title The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
title_full The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
title_fullStr The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
title_full_unstemmed The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
title_short The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
title_sort influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515428/
https://www.ncbi.nlm.nih.gov/pubmed/18827918
work_keys_str_mv AT tautenhahnjoerg theinfluenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT lobmannralf theinfluenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT koenigbrigitte theinfluenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT halloulzuhir theinfluenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT lipperthans theinfluenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT buergerthomas theinfluenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT tautenhahnjoerg influenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT lobmannralf influenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT koenigbrigitte influenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT halloulzuhir influenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT lipperthans influenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration
AT buergerthomas influenceofpolymorbidityrevascularizationandwoundtherapyonthehealingofarterialulceration